09:40 AM EST - Aurora Cannabis Inc. : Announced its financial and operational results for the second-quarter 2026 period ending September 30, 2025. The company expands YoY Global Medical Cannabis Net Revenue by 15% to a record $70.5 million. It also increases International Medical Cannabis Net Revenue by 22% to Record $42.7 million, and delivered Adjusted EBITDA growth of 52%, reaching $15.4 million. Aurora Cannabis Inc.
shares T.ACB are trading unchanged at $6.42.
